207 related articles for article (PubMed ID: 8482557)
21. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center.
Wils J; van Geuns H
Am J Clin Oncol; 1989 Jun; 12(3):251-4. PubMed ID: 2658540
[TBL] [Abstract][Full Text] [Related]
23. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
Ojeda B; Llanos M; Brunet J; Lacasta A; Alonso MC; Rueda A; Delgado E; Badía J; López López JJ
Med Clin (Barc); 1995 Feb; 104(5):165-9. PubMed ID: 7877374
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group Study.
de Oliveira CF; Lacave AJ; Villani C; Wolff JP; di Re F; Namer M; Maskens A; George M; Dalesio O; Rotmensz N
Eur J Gynaecol Oncol; 1990; 11(5):323-30. PubMed ID: 2097149
[TBL] [Abstract][Full Text] [Related]
25. A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.
Kirmani S; Braly PS; McClay EF; Saltzstein SL; Plaxe SC; Kim S; Cates C; Howell SB
Gynecol Oncol; 1994 Sep; 54(3):338-44. PubMed ID: 8088611
[TBL] [Abstract][Full Text] [Related]
26. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
28. [Survival in ovarian cancer treated in a gynecological department of a central hospital].
Dragsted NO; Nørgaard M; Bøsling KB
Ugeskr Laeger; 1997 May; 159(20):3003-9. PubMed ID: 9190729
[TBL] [Abstract][Full Text] [Related]
29. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide.
Gershenson DM; Copeland LJ; Kavanagh JJ; Stringer CA; Saul PB; Wharton JT
Obstet Gynecol; 1987 Nov; 70(5):765-9. PubMed ID: 3658288
[TBL] [Abstract][Full Text] [Related]
30. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
Richman CM; Podczaski E; Weiser PA; Herbst AL
Oncology; 1986; 43(1):12-7. PubMed ID: 3079898
[TBL] [Abstract][Full Text] [Related]
31. Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma.
Böhm S; Oriana S; Spatti G; Di Re F; Breasciani G; Pirovano C; Grosso I; Martini C; Caraceni A; Pilotti S; Zunino F
Oncology; 1999; 57(2):115-20. PubMed ID: 10461057
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparison of cisplatin plus epirubicin or doxorubicin for advanced epithelial ovarian carcinoma. A multicenter trial.
Homesley HD; Harry DS; O'Toole RV; Hoogstraten B; Franklin EW; Cavanagh D; Nahhas WA; Smith JJ; Lovelace JV
Am J Clin Oncol; 1992 Apr; 15(2):129-34. PubMed ID: 1553900
[TBL] [Abstract][Full Text] [Related]
33. Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. The Gruppo Oncologico Nord Ovest.
Chiara S; Lionetto R; Campora E; Oliva C; Merlini L; Bruzzi P; Rosso R; Conte PF
Eur J Cancer; 1995; 31A(3):296-301. PubMed ID: 7786592
[TBL] [Abstract][Full Text] [Related]
34. High-dose platinum chemotherapy in advanced ovarian cancer: a phase II study.
Bertelsen K; Bastholt L
Gynecol Oncol; 1992 Jan; 44(1):79-82. PubMed ID: 1730430
[TBL] [Abstract][Full Text] [Related]
35. High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.
Hunter RE; Griffin TW; Stevens S; Roman LD; Bokhari F; Reale FR; Tak WK; Fitzgerald TJ; Dillon MB; Rose PG
Cancer; 1991 Nov; 68(9):1890-4. PubMed ID: 1655227
[TBL] [Abstract][Full Text] [Related]
36. Treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin.
Cormio G; Maneo A; Gabriele A; Zanetta G; Losa G; Lissoni A
Am J Clin Oncol; 1997 Apr; 20(2):143-5. PubMed ID: 9124187
[TBL] [Abstract][Full Text] [Related]
37. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
[TBL] [Abstract][Full Text] [Related]
38. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).
Cohen CJ; Goldberg JD; Holland JF; Bruckner HW; Deppe G; Gusberg SB; Wallach RC; Kabakow B; Rodin J
Am J Obstet Gynecol; 1983 Apr; 145(8):955-67. PubMed ID: 6404174
[TBL] [Abstract][Full Text] [Related]
39. Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: effect of treatment and incidence of intracranial metastases.
Budd GT; Webster KD; Reimer RR; Martimbeau P; Livingston RB
J Surg Oncol; 1983 Nov; 24(3):192-5. PubMed ID: 6685214
[TBL] [Abstract][Full Text] [Related]
40. Results of the combination of cisplatin, adriamycin and cyclophosphamide in the treatment of ovarian carcinoma.
Russo A; Gebbia V; Palmeri S; Geraci P; Maneschi F; Guarnieri G; Carollo F; Leonardi V; Meli M; Gebbia N
Eur J Gynaecol Oncol; 1993; 14(3):228-33. PubMed ID: 8508880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
